Assertio Therapeutics's total assets for Q3 2024 were $276.00M, a decrease of -1.23% from the previous quarter. ASRT total liabilities were $145.48M for the fiscal quarter, a -1.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.